BackHarvard Bioscience Overview

Harvard Bioscience Total Assets

Harvard Bioscience's total assets is $76M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$76.29M
↓ 4.75% YoYΔ $-3.81M vs prior year quarter

Peer trimmed avg / median

Loading

Harvard Bioscience Total Assets History

Loading

Harvard Bioscience vs. peers: Total Assets Comparison

Loading

Harvard Bioscience Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Harvard Bioscience (HBIO) FAQ

The latest total assets for HBIO is $76M as of June 2026. That compares with $80M in the prior-year period — down 4.8% year over year. Investors often review this figure alongside Harvard Bioscience's historical trend and sector peers before judging valuation or financial health.

Over the past year, HBIO's total assets moved from $80M to $76M — a 4.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Harvard Bioscience's operating scale or balance-sheet position.

A total assets figure of $76M for HBIO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting HBIO's total assets ($76M), review year-over-year change from $80M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Harvard Bioscience's total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.